Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Participate in the BofA Securities 2024 Health Care Conference Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) announced its participation in the BofA Securities 2024 Health Care Conference. The event is scheduled for May 14, 2024, at the Encore Hotel in Las Vegas, Nevada. Chief Financial Officer Doretta Mistras and Chief R&D Officer Philippe Martin will represent the company in a fireside chat during the conference. Interested individuals can attend via a live webcast, with an archived version available later.
Price reaction · baseline $11.63 (2024-05-01 close) · hit after-hours · clean, no other VTRS news in the window
day 0 close
-0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference showcases Viatris' commitment to engaging with investors.
  • Bringing together key executives shows transparency and readiness to discuss company strategies and future outlook.
  • The company's extensive portfolio and global reach highlight its positive impact on healthcare access.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , May 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 14, 2024 . Chief Financial Officer Doretta Mistras and Chief R&D Officer Philippe Martin will represent the company in a fireside chat scheduled at 10 a.m. PT / 1 p.m. ET .
Interested parties can access a live webcast of the event at investor.viatris.com . An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc . (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When is Viatris participating in the 2024 Health Care Conference?

Viatris will participate on May 14, 2024.

Who will represent Viatris at the conference?

CFO Doretta Mistras and CDO Philippe Martin will represent Viatris.

How can I access the Viatris conference webcast?

The webcast is available at investor.viatris.com.

What is Viatris's mission?

Viatris aims to empower people to live healthier at every life stage.

How many patients does Viatris supply annually?

Viatris supplies high-quality medicines to approximately 1 billion patients yearly.

Last updated: May 2, 2024